Digital Biotechnology Archives - Healthentia https://healthentia.com/tag/digital-biotechnology/ Fri, 04 Jul 2025 09:19:43 +0000 en-US hourly 1 https://healthentia.com/wp-content/uploads/2020/04/cropped-favicon_512-32x32.png Digital Biotechnology Archives - Healthentia https://healthentia.com/tag/digital-biotechnology/ 32 32 193384636 ‘Discovering biomarkers’ https://healthentia.com/discovering-biomarkers/ Mon, 19 Oct 2020 10:39:56 +0000 https://healthentia.com/?p=18386 In Innovation Sprint we believe in the potential of the ‘missing data’ in clinical studies, such as lifestyle, activity, nutrition, sleep, to derive conclusions about the efficacy of treatments, as well as to bridge the gap between clinical research and eHealth/DTx. In the context of exploring ways to make use of such data, we started...

The post ‘Discovering biomarkers’ appeared first on Healthentia.

]]>
In Innovation Sprint we believe in the potential of the ‘missing data’ in clinical studies, such as lifestyle, activity, nutrition, sleep, to derive conclusions about the efficacy of treatments, as well as to bridge the gap between clinical research and eHealth/DTx. In the context of exploring ways to make use of such data, we started around a year ago the Digital Biotech activity, which involves the discovery of digital composite contextual biomarkers.

A biomarker is a naturally occurring characteristic by which a pathological or physiological process can be identified. A digital biomarker comprises of objective, quantifiable physiological and behavioral data, measured utilising digital portable, wearable, implantable or digestible devices, to be used to predict and manage health-related outcomes.

Innovation Sprint has built a composite contextual biomarker-based οn multiple aspects of Real-World Data (RWD), collected from people unobtrusively, while following-up their normal living routine. It is composite in the sense that it is not based on a single measurement, but rather on multiple diverse measurements (objective RWD) and peoples’ reports (subjective RWD). It is contextual in the sense that not only the person is measured, but also the person’s lifestyle context: social and environmental aspects complement the more traditional physiological and psychological ones.

Our RWD

At Innovation Sprint we are strong advocates of the empirical knowledge that lifestyle is a strong determinant of health. Hence our biomarker is based on RWD spanning four important aspects of a person’s lifestyle:

◾ Physiological RWD quantifies physical behaviour (active vs sedentary lifestyle as measured by steps walked, floors climbed, activity types, minutes in different intensity levels or heart rate zones, resting heart rate, sleep characteristics) and includes body info (height, weight, gender, race), nutrition (water, other liquids, food) and symptoms (body temperature, cough, diarrhea, headache, nausea, pain, etc.).

◾ Psychological RWD quantifies at a simple level mood, and in more complex situations mental state collected via elaborate, domain-specific questionnaires. Measurements can also play a role, either directly e.g. facial expression recognition, or indirectly, e.g. weather where people are living).

◾ Social RWD quantifies social activity of people. This can be measured indirectly from the usage of the phone (diversity, duration, frequency of calls) and social media (diversity, number, frequency of interactions). More direct information can be reported using questionnaires on activities with friends, family or co-workers.

◾ Environmental RWD indicates the quality of life. Usually, reported by the users. Measurements of living or working environment quality are made with commercial devices (e.g. air quality meters).

AI for discovering our biomarker

Biomarker discovery at Innovation Sprint is done in three stages

◾ Definition stage, where the domain experts select the clinically significant outcomes that need to be predicted by the biomarker(s).

◾ Manual RWD selection stage, where domain knowledge is applied to refine our generic RWD selection into those lifestyle aspects that are relevant to the disease/condition in question.

◾ Iterative design stage: Machine Learning/AI algorithms are used to train a proprietary classifier using the elected RWD to predict the selected clinically significant outcomes. The classifier is applied on new data  yielding predictions and insights leading to digital therapeutics.

Validating our approach

We employed RWD collected over 7 years to train a biomarker that predicts significant weight changes. Such a biomarker is important for patients with several diseases (e.g. NAFLD), as well as for the general population interested in well-being. We achieved over 80% or correct prediction of the outcome, while we also analysed the different RWD aspects that led each individual to positive or negative outcomes, in order to offer personalized coaching services.

 

As we speak, we are utilising the same approach in other therapeutic areas, e.g. cervical cancer, to predict low toxicity events. Starting from 2021 we will validate this hypothesis in much larger cohorts, targeting –among others- COPD patients with Cardiovascular Disease comorbidities.

We will keep you update on our observations and findings!

Aristodemos Pnevmatikakis
R&D Director, Innovation Sprint

The post ‘Discovering biomarkers’ appeared first on Healthentia.

]]>
18386
Boosting our Digital Biomarker Activity with the new Coaching Program https://healthentia.com/blsi-coaching-program/ Tue, 01 Sep 2020 09:55:10 +0000 https://healthentia.com/?p=18322 Innovation Sprint is participating in a new coaching program, developed by incubators.brussels, all incubators of the Brussels-Capital Region and supported by Innoviris Brussels, to boost our #HealthentiaDigitalBiomarker activity. In this program, Innovation Sprint is receiving coaching and mentoring services by domain experts to strengthen the Digital Biomarker activity as a new pillar for our product...

The post Boosting our Digital Biomarker Activity with the new Coaching Program appeared first on Healthentia.

]]>

Innovation Sprint is participating in a new coaching program, developed by incubators.brussels, all incubators of the Brussels-Capital Region and supported by Innoviris Brussels, to boost our #HealthentiaDigitalBiomarker activity. In this program, Innovation Sprint is receiving coaching and mentoring services by domain experts to strengthen the Digital Biomarker activity as a new pillar for our product Healthentia.

Healthentia Digital Biomarker activity introduces a novel approach of using RWD in clinical studies (among them physiological, psychological, sociological, and environmental information) to discover digital contextual biomarkers by means of Machine Learning algorithms. This activity has already resulted in evidence about the prediction capability of such a digital biomarker that can project clinical endpoints and drive – if used outside the context of a clinical study – eHealth and DTx services.

As incubees of BLSI, one of the program's affiliated incubators, together with the relevance of our scientific research activity makes Innovation Sprint eligible to the program's priorities and therefore we can receive support and promotion of our progress from domain experts.

 

Program Features

This program has some features that make it different from the others.

• Initially, it will work as a diagnostic tool that will identify the points on which to work in priority and their progress during the program. It is essentially a personalized journey that will be adjusted according to the needs and the stage of maturity of each startup.

• It is also a “lean” and iterative approach as on the one hand the strategic aspects are discussed with an advisory board (composed of highly qualified coaches and entrepreneurs). And on the other hand, the operational aspects are dealt with by experienced coaches and experts.

• Finally there are the individual and collective coaching sessions, where the collective sessions may involve start-ups from the other 3 incubators.

Program Expectations

• We expect that the program will assist our effort to refine our strategy and address the new market of Digital Biotechnology, exploiting the prosperous ecosystem of the region; thus achieving a high impact.

 

 

The post Boosting our Digital Biomarker Activity with the new Coaching Program appeared first on Healthentia.

]]>
18322